4,302 research outputs found

    ๋‹น๋‡จ ํ™˜์ž์—์„œ ๊ธฐ๊ณ„ํ•™์Šต์„ ์ด์šฉํ•œ ์ƒ๋ฆฌํ•™์  ์ง€ํ‘œ ๋ฐ ์œ„ํ—˜์š”์ธ์ด ์‹ฌํ˜ˆ๊ด€๊ณ„ ์˜ˆํ›„์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ์— ๋Œ€ํ•œ ๊ฒ€์ฆ

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ (๋ฐ•์‚ฌ) -- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ์˜๊ณผ๋Œ€ํ•™ ์˜ํ•™๊ณผ, 2020. 8. ๊ตฌ๋ณธ๊ถŒ.Background and Objectives: Current European Society of Cardiology and European Association for Cardio-Thoracic Surgery guidelines recommend fractional flow reserve (FFR) measurement as a standard invasive method to identify the ischemia-causing coronary lesions. However, patients after therapeutic procedures still suffer adverse cardiovascular events even after deferral of revascularization according to FFR, potentially due to the presence of microvascular dysfunction that may cause ischemia or foster the progression of obstructive disease. Coronary microvascular dysfunction (CMD) is more frequently observed in patients with diabetes mellitus (DM) and is a major determinant of long-term adverse outcome. Since comprehensive physiologic assessment enables the evaluation of microvascular function which could not be fully demonstrated by angiography, we sought to investigate the prognostic implication of invasive physiologic index-defined CMD in patients with DM and coronary artery disease (part I). Increasing evidence showed that machine learning can provide tools to assist physicians during diagnosis and treatment of diverse clinical conditions, including myocardial infarction. Therefore, we sought to study using machine learning algorithms with an expanded sample size, to validate the physiologic indices and find out the valuable risk factors for cardiovascular outcomes in patients with DM and coronary artery disease (part II). Methods: Part 1: Two hundred and eighty-three patients with available FFR and index of microcirculatory resistance (IMR) were selected from the 3V FFR-FRIENDS study. Patients were classified according to the presence of DM and CMD into group A (DM-, CMD-), group B (DM-, CMD+), group C (DM+, CMD-), and group D (DM+, CMD+). Primary outcome was a major adverse cardiac event (MACE, a composite of cardiac death, myocardial infarction and ischemia-driven revascularization) at 2 years. Part 2: Seven hundred and fourteen patients (235 patients with DM) with deferred coronary revascularization according to FFR (>0.80) were included. This registry hitherto is the biggest cohort whose patients were fully assessed by comprehensive physiologic indices. Comprehensive physiologic evaluation, including coronary flow reserve (CFR), IMR and FFR, was performed at the time of revascularization deferral. The median values of CFR (2.88), FFR (0.88) and IMR (17.85) were used to classify high or low CFR, FFR, and IMR groups. Information gains of variables with 5,000-permutation resampling, minimal depth and Boruta algorithms were used for feature selection. Furthermore, prognostic models were compared using c-index. In this part, patient-oriented composite outcome (POCO) at 5 years, including all-cause death, any myocardial infarction, and any revascularization, was the primary outcome. Results: Part 1: DM population showed significantly higher risk of MACE compared with non-DM population (HR 4.88, 95% CI 1.54-15.48, p=0.003). MACE at 2-year among four groups were 2.2%, 2.0%, 7.0%, and 18.5%, respectively. Group D showed significantly higher risk of MACE compared with group A (HR 8.98, 95% CI 2.15-37.41, p=0.003). The multivariable regression analysis showed the presence of DM and CMD was an independent predictor of 2-year MACE (HR 11.24, 95% CI 2.53-49.88, p=0.002) and integrating CMD into a model with DM increased discriminant ability (C-index 0.683 vs. 0.710, p=0.010, integrated discrimination improvement 0.015, p=0.040). Part 2: Compared with non-DM population, DM population showed a higher risk of POCO at 5 years (HR 2.49, 95% CI 1.64-3.78, p<0.001). Low CFR group had a higher risk of POCO than high CFR group (HR 3.22, 95% CI 1.74-5.97, p<0.001) only in DM population. In contrast, CFR values could not differentiate the risk of POCO in non-DM population. There was a significant interaction between CFR and the presence of DM regarding the risk of POCO (interaction p=0.025). Independent predictors of POCO at 5 years were low CFR and family history of coronary artery disease in DM population, and percent diameter stenosis and multi-vessel disease in non-DM population. Among all angiographic and physiologic parameters, CFR showed the highest information gain. In DM population, CFR, consistently, was the most important feature followed by Age and FFR using Minimal Depth algorithm. Moreover, CFR was the valuable features to predict POCO using Boruta algorithm in DM population. In DM population, adding clinical risk factors (c-index 0.75 0.65-0.85, p=0.500) or clinical risk factors and invasive parameters together (c-index 0.75, 95%CI 0.65-0.85, p=0.535) into features from Boruta (c-index 0.73, 95% CI 0.63-0.83) did not show a better discriminant ability. Conclusions: The patients with DM and CMD were associated with increased risk of cardiovascular events. Integration of CMD improved risk stratification to predict the occurrence of MACE. The importance of risk factors for cardiovascular outcomes is different according to the presence of DM. CFR consistently was the important prognostic factor in patients with DM regardless of methods. Machine learning could help find out the most effective combination with acceptable numbers of features for better outcome prediction.๋ฐฐ๊ฒฝ ๋ฐ ๋ชฉ์ : ์œ ๋Ÿฝ์‹ฌ์žฅํ•™ํšŒ (European Society of Cardiology) ๋ฐ ์œ ๋Ÿฝ์‹ฌ์žฅ์™ธ๊ณผํ˜‘ํšŒ (European Society of Cardio-Thoracific Academy) ์ง€์นจ์—์„œ ๊ด€์ƒ๋™๋งฅ ํ—ˆํ˜ˆ ์ง„๋‹จ์„ ์œ„ํ•œ ์นจ์Šต์  ํ‘œ์ค€ ๋ฐฉ๋ฒ•์œผ๋กœ ๋ถ„ํšํ˜ˆ๋ฅ˜์˜ˆ๋น„๋ ฅ (FFR, Fractal Flow Reserve) ์ธก์ •์„ ๊ถŒ๊ณ ํ•˜๊ณ  ์žˆ์Œ. ๊ทธ๋Ÿฌ๋‚˜ ํ‘œ์ค€์ง€์นจ์œผ๋กœ ์น˜๋ฃŒ๋ฐ›์€ ์ผ๋ถ€ ํ™˜์ž๋“ค์€ ์—ฌ์ „ํžˆ ์‹ฌํ˜ˆ๊ด€ ์‚ฌ๊ฑด์„ ๊ฒช์Œ. ์ด๋Š” ์ž ์žฌ์ ์œผ๋กœ ํ—ˆํ˜ˆ์„ ์œ ๋ฐœํ•˜๊ฑฐ๋‚˜ ํ์‡„์„ฑ ์งˆํ™˜์˜ ์ง„ํ–‰์„ ์ด‰์ง„ํ•  ์ˆ˜ ์žˆ๋Š” ๋ฏธ์„ธํ˜ˆ๊ด€ ๊ธฐ๋Šฅ์žฅ์•  ๋•Œ๋ฌธ์ž„. ์ด๋Ÿฐ ๋ฏธ์„ธ๊ธฐ๋Šฅ์žฅ์• ๋Š” ๊ด€์ƒ๋™๋งฅ ์กฐ์˜์ˆ ๋กœ ํ‰๊ฐ€ํ•  ์ˆ˜ ์—†์Œ. ๊ด€์ƒ๋™๋งฅ๋ฏธ์„ธํ˜ˆ๊ด€๊ธฐ๋Šฅ์žฅ์• ๋Š” ๋‹น๋‡จํ™˜์ž์—์„œ ๋” ์ž์ฃผ ์ƒ๊ธฐ๊ณ  ์žฅ๊ธฐ ์˜ˆํ›„์˜ ์ฃผ์š” ์œ„ํ—˜์š”์ธ์ž„. ์ข…ํ•ฉ์ ์ธ ์ƒ๋ฆฌํ•™์  ํ‰๊ฐ€๋กœ ๋ฏธ์„ธํ˜ˆ๊ด€ ๊ธฐ๋Šฅ์˜ ํ‰๊ฐ€๊ฐ€ ๊ฐ€๋Šฅํ•˜๊ธฐ ๋•Œ๋ฌธ์— ๋‹น๋‡จ ๋ฐ ๊ด€์ƒ๋™๋งฅ์งˆํ™˜์ด ์žˆ๋Š” ํ™˜์ž์—์„œ ๋Œ€ํ•œ ์นจ์Šต์  ์ƒ๋ฆฌ์ง€ํ‘œ๋กœ ์ •์˜ํ•œ ๋ฏธ์„ธํ˜ˆ๊ด€ ์žฅ์• ๊ฐ€ ์˜ˆํ›„์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ์„ ์กฐ์‚ฌํ•˜๊ณ ์ž ๋ณธ ์—ฐ๊ตฌ์˜ Part 1์„ ์‹œํ–‰ํ•˜์˜€์Œ. ๋˜ ์ƒ˜ํ”Œ ํฌ๊ธฐ๊ฐ€ ํ™•์žฅ๋œ ๋ณธ ์—ฐ๊ตฌ์˜ Part 2์—์„œ๋Š” ๊ธฐ๊ณ„ํ•™์Šต์„ ์ด์šฉํ•˜์—ฌ ๋‹น๋‡จ ํ™˜์ž์—์„œ ์ƒ๋ฆฌํ•™์  ์ง€ํ‘œ ๋ฐ ์œ„ํ—˜์š”์ธ์ด ์‹ฌํ˜ˆ๊ด€๊ณ„ ์˜ˆํ›„์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ์„ ๊ฒ€์ฆํ•˜๊ณ ์ž ์‹œํ–‰ํ•˜์˜€์Œ. ๋ฐฉ๋ฒ•: ๋ณธ ์—ฐ๊ตฌ์˜ ์ฒซ๋ฒˆ์งธ ๋ถ€๋ถ„์€ 3V FFR-FRIENS study์—์„œ ์‚ฌ์šฉ ๊ฐ€๋Šฅํ•œ FFR ๋ฐ index of microcirculatory resistance (IMR)๊ฐ€ ์žˆ๋Š” ํ™˜์ž 283๋ช…์ด ์„ ํƒ๋จ. CMD (coronary microvascular dysfunction)๋Š” IMRโ‰ฅ25U๋กœ ์ •์˜ํ•จ. ํ™˜์ž๋Š” DM๊ณผ CMD์— ๋”ฐ๋ผ ๊ทธ๋ฃน A(DM-, CMD-), ๊ทธ๋ฃน B(DM-, CMD+), ๊ทธ๋ฃน C(DM+, CMD-), ๊ทธ๋ฃน D(DM+, CMD+)๋กœ ๋ถ„๋ฅ˜๋จ. ์ด ์„ ํ–‰ ์—ฐ๊ตฌ์—์„œ 1์ฐจ ํ‰๊ฐ€๋ณ€์ˆ˜๋Š” 2๋…„์˜ major adverse cardiac event (MACE, ์‹ฌ์žฅ์‚ฌ, ์‹ฌ๊ทผ๊ฒฝ์ƒ‰ ๋ฐ ํ—ˆํ˜ˆ์„ฑ ๊ธฐ๋ฐ˜ ํ˜ˆ๊ด€์žฌ๊ฐœํ†ต์ˆ )๋กœ ์ •์˜ํ•จ. ๋‘๋ฒˆ์งธ ๋ถ€๋ถ„์€ Korea-Japan-Spain registry์—์„œ FFR (>0.80)์— ๋”ฐ๋ผ ๊ด€์ƒ๋™๋งฅ ์žฌ๊ฐœํ†ต์ˆ ์ด ์ง€์—ฐ๋˜๊ณ  ๊ด€์ƒ๋™๋งฅํ˜ˆ๋ฅ˜์˜ˆ๋น„๋ ฅ(CFR, coronary flow reserve), IMR์„ ํฌํ•จํ•œ ์ข…ํ•ฉ์ ์ธ ์ƒ๋ฆฌํ•™์  ํ‰๊ฐ€๊ฐ€ ์ด๋ฃจ์–ด์ง„ ํ™˜์ž 714๋ช…(DM์„ ๊ฐ€์ง„ ํ™˜์ž 235๋ช…)์ด ์„ ํƒ๋จ. CFR, IMR, FFR์˜ ๋†’์€ ๊ทธ๋ฃน ๋˜๋Š” ๋‚ฎ์€ ๊ทธ๋ฃน์„ ๋ถ„๋ฅ˜ํ•˜๋Š”๋ฐ ์ค‘๊ฐ„๊ฐ’ CFR(2.88), FFR(0.88), IMR(17.85)์ด ์‚ฌ์šฉ๋จ. ์ด ๋ถ€๋ถ„์˜ 1์ฐจ ํ‰๊ฐ€๋ณ€์ˆ˜๋Š” POCO (patient-oriented composite outcome) 5๋…„ ๋‚ด์˜ ๋ชจ๋“  ์›์ธ ์‚ฌ๋ง, ์‹ฌ๊ทผ๊ฒฝ์ƒ‰, ๋ชจ๋“  ํ˜ˆ๊ด€์žฌ๊ฐœํ†ต์ˆ ๋กœ ์ •์˜ํ•จ. ๊ฒฐ๊ณผ: ์ฒซ ๋ถ€๋ถ„์—์„œ ๋‹น๋‡จ ํ™˜์ž๋“ค์€ ๋น„๋‹น๋‡จํ™˜์ž์— ๋น„ํ•ด MACE์˜ ์œ„ํ—˜์„ฑ์ด ๋†’์Œ(HR 4.88, 95% CI 1.54-15.48, p=0.003). 4๊ฐœ ๊ทธ๋ฃน์˜ 2๋…„ MACE๋Š” ๊ฐ๊ฐ 2.2%, 2.0%, 7.0%, 18.5%. ๊ทธ๋ฃน D๋Š” ๊ทธ๋ฃน A์— ๋น„ํ•ด MACE์˜ ์œ„ํ—˜๋„๊ฐ€ ํ˜„์ €ํžˆ ๋†’์Œ(HR 8.98, 95% CI 2.15-37.41, p=0.003). ๋‹ค๋ณ€๋Ÿ‰ ํšŒ๊ท€ ๋ถ„์„์—์„œ 2๋…„ MACE์˜ ๋…๋ฆฝ์ ์ธ ์˜ˆ์ธก์ธ์ž๋Š” CMD๋ฅผ ๋™๋ฐ˜ํ•œ ๋‹น๋‡จํ™˜์ž (HR 11.24, 95% CI 2.53-49.88, p=0.002). CMD๋ฅผ ๋‹น๋‡จ์— ์ถ”๊ฐ€ํ–ˆ์„๋•Œ ์˜ˆ์ธก ๋Šฅ๋ ฅ์ด ํ–ฅ์ƒ๋จ(C-index 0.683 vs 0.710, p=0.010). ๋‘๋ฒˆ์งธ ๋ถ€๋ถ„์—์„œ, ๋น„๋‹น๋‡จ๊ตฐ๊ณผ ๋น„๊ตํ–ˆ์„ ๋•Œ, ๋‹น๋‡จ๊ตฐ์€ 5๋…„ POCO์˜ ์œ„ํ—˜์„ฑ์ด ๋” ๋†’์Œ(HR 2.49, 95% CI 1.64-3.78, p<0.001). ๋‹น๋‡จ๊ตฐ์—์„œ ๋‚ฎ์€ CFR ๊ทธ๋ฃน์€ ๋†’์€ CFR ๊ทธ๋ฃน๋ณด๋‹ค POCO์˜ ์œ„ํ—˜์ด ๋†’์Œ(HR 3.22, 95% CI 1.74-5.97, p<0.001). CFR ๊ฐ’์€ ๋น„๋‹น๋‡จ๊ตฐ์—์„œ POCO์˜ ์œ„ํ—˜์„ ๊ตฌ๋ณ„ํ•  ์ˆ˜ ์—†์Œ. POCO์˜ ์œ„ํ—˜์„ฑ์„ ์˜ˆ์ธกํ•จ์— ์žˆ์–ด์„œ CFR๊ณผ ๋‹น๋‡จ ์‚ฌ์ด์— ์œ ์˜ํ•œ ์ƒํ˜ธ์ž‘์šฉ์ด ์žˆ์—ˆ๋‹ค(interaction p=0.025). 5๋…„ POCO์— ๋Œ€ํ•œ ๋…๋ฆฝ์ ์ธ ์˜ˆ์ธก ์ธ์ž๋Š” ๋‹น๋‡จ๊ตฐ์—์„œ ๋‚ฎ์€ CFR๊ณผ ๊ด€์ƒ๋™๋งฅ ๊ฐ€์กฑ๋ ฅ, ๋น„๋‹น๋‡จ๊ตฐ์—์„œ ๊ด€์ƒ๋™๋งฅ ์งˆํ™˜์˜ percent diameter stenosis์™€ ๋‹คํ˜ˆ๊ด€ ์งˆํ™˜์ž„. ๋‹น๋‡จ๊ตฐ์—์„œ POCO๋ฅผ ์˜ˆ์ธกํ•จ์— ์žˆ์–ด์„œ ๋‹ค๋ฅธ ์š”์ธ์— ๋น„ํ•ด CFR์€ ๊ฐ€์žฅ ๋งŽ์€ ์ •๋ณด๋ฅผ ๊ฐ€์ง€๊ณ  ์žˆ์—ˆ์Œ. "Minimum Depth" ์•Œ๊ณ ๋ฆฌ์ฆ˜์„ ์‚ฌ์šฉํ–ˆ์„ ๋•Œ CFR์€ ๊ฐ€์žฅ ์ค‘์š”ํ•œ ์˜ˆ์ธก์š”์ธ์ด๊ณ  "Boruta" ์•Œ๊ณ ๋ฆฌ์ฆ˜์„ ์‚ฌ์šฉํ–ˆ์„ ๋•Œ ์˜๋ฏธ ์žˆ๋Š” ์š”์ธ์œผ๋กœ ๋‚˜ํƒ€๋‚จ. ๋‹น๋‡จ๊ตฐ์—์„œ ์ž„์ƒ์  ์œ„ํ—˜ ์ธ์ž(c-index 0.75 0.65-0.85, p=0.500) ํ˜น์€ ์ž„์ƒ์  ์‹œ์ˆ ์  ์œ„ํ—˜์ธ์ž(c-index 0.75, 95%CI 0.65-0.85, p=0.535)๋ฅผ ๋™์‹œ์— Boruta ์•Œ๊ณ ๋ฆฌ์ฆ˜์—์„œ ์„ ํƒ๋˜์–ด์ง„ ์œ„ํ—˜์ธ์ž๋กœ ๊ตฌ์„ฑ๋œ ๋ชจ๋ธ(c-index 0.73, 95% CI 0.63-0.83)์— ์ถ”๊ฐ€ํ•˜์˜€์„ ๋•Œ ๋ชจ๋ธ์˜ ์˜ˆ์ธก๋ ฅ์€ ์œ ์˜ํ•˜๊ฒŒ ๋†’์•„์ง€์ง€ ์•Š์•˜์Œ. ๊ฒฐ๋ก : CMD๋ฅผ ๋™๋ฐ˜ํ•œ ๋‹น๋‡จ๋Š” ์‹ฌํ˜ˆ๊ด€ ์งˆํ™˜ ์œ„ํ—˜์˜ ์ฆ๊ฐ€์™€ ๊ด€๋ จ์ด ์žˆ์Œ. ๋‹น๋‡จํ™˜์ž์—์„œ CMD์˜ ์ถ”๊ฐ€๋Š” MACE๋ฐœ์ƒ์˜ ์˜ˆ์ธก๋ ฅ์„ ๋†’์ž„. ๊ด€์ƒ๋™๋งฅ ์ƒ๋ฆฌํ•™์  ์ง€ํ‘œ์™€ ์œ„ํ—˜ ์ธ์ž๋“ค์ด ์˜ˆํ›„์— ๋ฏธ์น˜๋Š” ์—ญํ• ์€ ๋‹น๋‡จ์—ฌ๋ถ€์— ๋”ฐ๋ผ ๋‹ค๋ฆ„. ์–ด๋–ค ๋ฐฉ๋ฒ•์„ ์‚ฌ์šฉํ•˜๋Š”์ง€ ๋ถˆ๊ตฌํ•˜๊ณ  CFR์€ ์˜ˆํ›„๋ฅผ ์˜ˆ์ธกํ•˜๋Š” ์ค‘์š”ํ•œ ์ง€ํ‘œ์ž„. ๊ธฐ๊ณ„ํ•™์Šต์€ ๊ฐ€์žฅ ํšจ๊ณผ์ ์ด๊ณ  ํšจ์œจ์ ์ธ ๋ณ€์ˆ˜์กฐํ•ฉ์„ ์ฐพ์•„ ์˜ˆํ›„๋ฅผ ๋” ์ž˜ ์˜ˆ์ธกํ•  ์ˆ˜ ์žˆ์Œ.Introduction 2 First Part 4 Methods 4 Results 7 Second Part 10 Methods 10 Results 16 Discussion 19 Conclusions 26 References 28 ๊ตญ๋ฌธ์ดˆ๋ก 58Docto

    Evaluation of pericoronary adipose tissue attenuation on CT

    Get PDF
    Pericoronary adipose tissue (PCAT) is the fat deposit surrounding coronary arteries. Although PCAT is part of the larger epicardial adipose tissue (EAT) depot, it has different pathophysiological features and roles in the atherosclerosis process. While EAT evaluation has been studied for years, PCAT evaluation is a relatively new concept. PCAT, especially the mean attenuation derived from CT images may be used to evaluate the inflammatory status of coronary arteries non-invasively. The most commonly used measure, PCATMA, is the mean attenuation of adipose tissue of 3 mm thickness around the proximal right coronary artery with a length of 40 mm. PCATMA can be analyzed on a per-lesion, per-vessel or per-patient basis. Apart from PCATMA, other measures for PCAT have been studied, such as thickness, and volume. Studies have shown associations between PCATMA and anatomical and functional severity of coronary artery disease. PCATMA is associated with plaque components and high-risk plaque features, and can discriminate patients with flow obstructing stenosis and myocardial infarction. Whether PCATMA has value on an individual patient basis remains to be determined. Furthermore, CT imaging settings, such as kV levels and clinical factors such as age and sex affect PCATMA measurements, which complicate implementation in clinical practice. For PCATMA to be widely implemented, a standardized methodology is needed. This review gives an overview of reported PCAT methodologies used in current literature and the potential use cases in clinical practice.</p

    THE USE OF BASEL SCORE IN EARLY DETECTION OF CORONARY LESION SEVERITY IN NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION AND UNSTABLE ANGINA PECTORIS

    Get PDF
    Early diagnosis of cardiac ischemia is crucial for effective management of acute myocardial infarction. The BASEL (Better Analysis of ST-segment Elevations and Depressions in a 12-leads-ECG) score has been shown to provide additional diagnostic value to the established electrocardiographic (ECG) criteria. This study aimed to evaluate the use of BASEL score to determine the severity of coronary lesions in patients with non-ST segment elevation acute coronary syndrome. This study used a cross-sectional approach and was conducted from January 2021 to January 2022. From a total of 90 subjects, more than three-quarters were male, while the mean age was 60.3 years. The median BASEL score was 2.3 (1โ€“4.2). GRACE 2.0 score had a mean of 97.3ยฑ26. The SYNTAX I score had a mean of 25ยฑ15.6, the SYNTAX II โ€“ PCI median score was 34.5 (25.9-42.4), and the SYNTAX II-CABG mean score was 23.4ยฑ11.9. The BASEL score showed a significant association with the SYNTAX I score both in univariate 2.60 (2.60-3.59),

    Intracoronary electrocardiogram as a direct measure of myocardial ischemia

    Get PDF
    The electrocardiogram is a valuable diagnostic method providing insight into pathologies of the heart, especially rhythm disorders or insufficient myocardial blood supply (myocardial ischemia). The commonly used surface ECG is, however, limited in detecting short-lasting myocardial ischemia, in particular in the territory of the left circumflex coronary artery supplying the postero-lateral wall of the left ventricle. Conversely, an ECG recorded in close vicinity to the myocardium, i.e., within a coronary artery (intracoronary ECG, icECG) has been thought to overcome these limitations. Since its first implementation during cardiac catheterization in 1985, icECG has shown ample evidence for its diagnostic value given the higher sensitivity for myocardial ischemia detection when compared to the surface ECG. In addition, icECG has been demonstrated to be a direct measure of myocardial ischemia in real-time, thus, providing valuable information during percutaneous coronary diagnostics and interventions. However, a lack of analysing systems to obtain and quantify icECG in real-time discourages routine use. The goals of this MD-PhD thesis are two-fold: First, to determine the diagnostic accuracy of icECG ST-segment shift during pharmacologic inotropic stress in comparison to established indices for coronary lesion severity assessment using quantitative angiographic percent diameter stenosis as reference (Project I). Second, to determine the optimal icECG parameter for myocardial ischemia detection and quantification (Project II and III). In essence, this thesis demonstrates that the icECG is an easy available diagnostic method providing highly accurate information on the amount of myocardial ischemia in real-time. Quantitative assessment of acute, transmural myocardial ischemia by icECG is most accurately performed by measuring ST-segment shift at the J-point, while the quantitative assessment during physical exercise, respectively its pharmacologic simulation, is most accurately performed by measuring ST-segment shift 60ms after the J-point

    Physiology and coronary artery disease: emerging insights from computed tomography imaging based computational modeling

    Get PDF
    Improvements in spatial and temporal resolution now permit robust high quality characterization of presence, morphology and composition of coronary atherosclerosis in computed tomography (CT). These characteristics include high risk features such as large plaque volume, low CT attenuation, napkin-ring sign, spotty calcification and positive remodeling. Because of the high image quality, principles of patient-specific computational fluid dynamics modeling of blood flow through the coronary arteries can now be applied to CT and allow the calculation of local lesion-specific hemodynamics such as endothelial shear stress, fractional flow reserve and axial plaque stress. This review examines recent advances in coronary CT image-based computational modeling and discusses the opportunity to identify lesions at risk for rupture much earlier than today through the combination of anatomic and hemodynamic information

    Cardiac computed tomography radiomics: an emerging tool for the non-invasive assessment of coronary atherosclerosis

    Get PDF
    In the last decades, significant advances have been made in the preventive approaches to cardiovascular disease. Even so, coronary artery disease remains one of the main causes of morbidity and mortality worldwide. Invasive imaging modalities, such as intravascular ultrasound or optical coherence tomography, have played a key role in the comprehension of the pathological processes underlying myocardial infarction and cerebrovascular disease. These imaging techniques have contributed greatly to the identification and phenotyping of the culprit lesion, the so-called vulnerable plaque. Coronary computed tomographic angiography (CCTA) has emerged in more recent years as the non-invasive modality of choice in the study of coronary atherosclerosis, showing in many studies a diagnostic yield comparable to invasive approaches. Moreover, being able to describe extra-luminal characteristics of the affected vessel, CCTA has greatly contributed towards shifting the attention of researchers from the mere quantification of luminal stenosis to the identification of adverse plaque features, which appear to have a stronger prognostic value. However, the identification of some of the hallmarks of vulnerable plaques is qualitative in nature and, therefore, subject to some degree of inter-reader variability. Moreover, CCTA is still unable to identify some fine markers of plaque vulnerability which can be detected by invasive techniques, such as neovascularization and plaque erosion, among others. Nonetheless, radiological images can be viewed as vast 3-D datasets which, via the use of recent technology, allow for the extraction of numerous quantitative features that may be used to accurately phenotype a given lesion. Radiomics is the process of extrapolating innumerable parameters from a given region of interest, with the goal of establishing correlations between quantitative variables and clinical data. These datasets can then be manipulated to create predictive models via the use of automated algorithms in a process called machine learning. As a result of these approaches, radiological images may offer information regarding the characterization of a plaque which can go much beyond the boundaries of what can be qualitatively asserted by the human eye, contributing to expanding the knowledge of the disease and ultimately assist clinical decisions. Thus far, radiomics has found its more consistent area of application in the field of oncology; to present date, the amount of clinical data regarding coronary artery disease is still relatively small, partly due to the technical difficulties associated with the implementation of such techniques to the study of a small and geometrically complex lesion such as the coronary plaque. The present review, after a summary of the imaging modalities most commonly used nowadays in the study of coronary plaques, will provide a perspective on the application of radiomic analysis to coronary artery disease

    CT-based fractional flow reserve: development and expanded application

    Get PDF
    Computations of fractional flow reserve, based on CT coronary angiography and computational fluid dynamics (CT-based FFR) to assess the severity of coronary artery stenosis, was introduced around a decade ago and is now one of the most successful applications of computational fluid dynamic modelling in clinical practice. Although the mathematical modelling framework behind this approach and the clinical operational model vary, its clinical efficacy has been demonstrated well in general. In this review, technical elements behind CT-based FFR computation are summarised with some key assumptions and challenges. Examples of these challenges include the complexity of the model (such as blood viscosity and vessel wall compliance modelling), whose impact has been debated in the research. Efforts made to address the practical challenge of processing time are also reviewed. Then, further application areas โ€“ myocardial bridge, renal stenosis and lower limb stenosis โ€“ are discussed along with specific challenges expected in these areas

    Impact of machine-learning CT-derived fractional flow reserve for the diagnosis and management of coronary artery disease in the randomized CRESCENT trials

    Get PDF
    Objective: To determine the potential impact of on-site CT-derived fractional flow reserve (CT-FFR) on the diagnostic efficiency and effectiveness of coronary CT angiography (CCTA) in patients with obstructive coronary artery disease (CAD) on CCTA. Methods: This observational cohort study included patients with suspected CAD who had been randomized to cardiac CT in the CRESCENT I and II trials. On-site CT-FFR was blindly performed in all patients with at least one โ‰ฅ 50% stenosis onย CCTA and no exclusion criteria for CT-FFR. We retrospectively assessed the effect of adding CT-FFR to the CT protocol in patients with a stenosis โ‰ฅ 50% on CCTA in terms of diagnostic effectiveness, i.e., the number of additional tests required to determine the final diagnosis, reclassification of the initial management strategy, and invasive coronary angiography (ICA) efficiency, i.e., ICA rate without โ‰ฅ 50% CAD. Results: Fifty-three patients out of the 372 patients (14%) had at least one โ‰ฅ 50% stenosis on CCTA of whom 42/53 patients (79%) had no exclusion criteria for CT-FFR. CT-FFR showed a hemodynamically significant stenosis (โ‰ค 0.80) in 27/53 patients (51%). The availability of CT-FFR would have reduced the number of patients requiring additional testing by 57%-points compared with CCTA alone (37/53 vs. 7/53, p < 0.001). The initial management strategy would have changed for 30 patients (57%, p < 0.001). Reserving ICA for patients with a CT-FFR โ‰ค 0.80 would have reduced the number of ICA following CCTA by 13%-points (p = 0.016). Conclusion: Implementation of on-site CT-FFR may change management and improve diagnostic efficiency and effectiveness in patients with obstructive CAD on CCTA. Key Points: โ€ข The availability of on-site CT-FFR in the diagnostic evaluation of patients with obstructive CAD on CCTA would have significantly reduced the number of patients requiring additional testing compared with CCTA alone. โ€ข The implementation of on-site CT-FFR would have changed the initial management strategy significantly in the patients with obstructive CAD on CCTA. โ€ข Restricting ICA to patients with a positive CT-FFR would have significantly reduced the ICA rate in patients with obstructive CAD on CCTA
    • โ€ฆ
    corecore